Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04987775 · ClinicalTrials.gov registry record · Early Phase 1

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

A Early Phase 1 study of Gulf War Syndrome, sponsored by Nova Southeastern University.

Recruiting
Registry status
Early Phase 1
Development phase
170
Enrollment target
7
Study locations

NCT04987775 is a Early Phase 1 study of Gulf War Syndrome that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 170 participants, above the 114-participant average among 8 other Gulf War Syndrome trials with a reported enrollment target (49% higher). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04987775, a Early Phase 1 study of Gulf War Syndrome, is actively recruiting participants, sponsored by Nova Southeastern University.

RECRUITING
Registry status
Early Phase 1
Development phase
170 participants
Enrollment target
7
Study locations

Study Summary

This mechanistic study will test if NAC affects chronic oxidative stress and depletion of antioxidants in GWI participants. Blood specimen collection and neuroimaging will be used to determine whether NAC affects serum glutathione (GSH) concentration and oxidative stress in the CNS when compared to placebo.

Conditions Studied

Gulf War Syndrome

Interventions

  • DRUG Placebo
  • DRUG N-Acetyl Cysteine

Study Locations (7)

California

  • VA Palo Alto Health Care System War Related Illness and Injury Study Center - Palo Alto

Florida

  • Nova Southeastern University - Fort Lauderdale

Massachusetts

  • Boston University Medical School - Boston

New Jersey

  • VA New Jersey Health Care System War Related Illness and Injury Study Center - East Orange

New York

  • Weill Cornell Medical College - New York

North Carolina

  • RTI International - Durham

Texas

  • Michael E. DeBakey VA Medical Center - Houston

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2023-11-30
Est. Completion 2026-04
Phase Early Phase 1

Sponsor

Nova Southeastern University

71 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04987775

The ClinicalTrials.gov registry entry for NCT04987775 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 114-participant average among 8 other Gulf War Syndrome trials with a reported enrollment target (49% higher). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gulf War Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04987775 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04987775 about?

NCT04987775 is a clinical study titled "GWICTIC: NAC Mechanistic Study in Gulf War Veterans". This mechanistic study will test if NAC affects chronic oxidative stress and depletion of antioxidants in GWI participants. Blood specimen collection and neuroimaging will be used to determine whether NAC affects serum glutathione (GSH) concentration and oxidative stress in the CNS when compared to ...

What is the current status of trial NCT04987775?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 170 participants. The study started on 2023-11-30. Estimated completion is 2026-04.

What conditions does trial NCT04987775 study?

This clinical trial studies the following conditions: Gulf War Syndrome.

What interventions are being tested in trial NCT04987775?

The interventions under investigation include: Placebo (DRUG), N-Acetyl Cysteine (DRUG).

Who is sponsoring clinical trial NCT04987775?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04987775 being conducted?

This trial has 7 study locations across California, Florida, Massachusetts, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gulf War Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gulf War Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.